Genetic polymorphisms in obesity‐related genes and endometrial cancer risk
Open Access
- 28 October 2011
- Vol. 118 (13) , 3356-3364
Abstract
BACKGROUND: Obesity is associated with circulating levels of adiponectin and leptin and endometrial cancer risk. Little is known about whether single nucleotide polymorphisms (SNPs) in the genes that encode adiponectin (ADIPOQ), leptin (LEP), adiponectin receptor 1 (ADIPOR1), adiponectin receptor 2 (ADIPOR2), and leptin receptor (LEPR) are associated with endometrial cancer. METHODS: The authors selected 87 tagging SNPs to capture common genetic variants in these 5 genes. These SNPs were evaluated in 1028 endometrial cancer cases and 1932 community controls recruited from Chinese women. Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs). RESULTS: Three of the 10 SNPs evaluated in the ADIPOQ gene were significantly associated with reduced cancer risk. The OR for women homozygous for the minor allele (A/A) for rs3774262 was 0.68 (95% CI, 0.48‐0.97) compared with women homozygous for the major allele (G/G). Similar results were found for SNPs rs1063539 and rs12629945 in ADIPOQ, which were in linkage disequilibrium with rs3774262. These associations became nonsignificant after Bonferroni correction was applied. Controls with the minor allele A at rs3774262 had lower weight, smaller waist and hip circumferences, and lower body mass index than controls with the major allele G (all P < .05). Women homozygous for the minor allele (T/T) of rs2071045 in the LEP gene also had significantly lower risk (OR, 0.70; 95% CI, 0.54‐0.90) than women homozygous for the major allele (C/C). No other SNPs in the LEP, ADIPOR1, ADIPOR2, or LEPR genes were found to be associated with cancer risk. CONCLUSIONS: Although a chance finding cannot be ruled out, the consistency of findings for gene‐endometrial cancer risk and gene‐obesity measurements suggests that genetic polymorphisms in the ADIPOQ gene may play a role in endometrial cancer development. Cancer 2011. © 2011 American Cancer Society.Keywords
This publication has 36 references indexed in Scilit:
- Total and High-Molecular-Weight Adiponectin in Breast Cancer:In Vitroandin VivoStudiesThe Journal of Clinical Endocrinology & Metabolism, 2007
- Nutritional factors in relation to endometrial cancer: A report from a population‐based case‐control study in Shanghai, ChinaInternational Journal of Cancer, 2007
- Physical activity and endometrial cancer risk: a review of the current evidence, biologic mechanisms and the quality of physical activity assessment methodsCancer Causes & Control, 2007
- Plasma Adiponectin Levels and Endometrial Cancer Risk in Pre- and Postmenopausal WomenThe Journal of Clinical Endocrinology & Metabolism, 2007
- Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in KoreaCancer Letters, 2006
- Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cellsBiochemical and Biophysical Research Communications, 2006
- Association between adiponectin, insulin resistance, and endometrial cancerCancer, 2006
- Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinomaBMC Cancer, 2006
- Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai WomenAmerican Journal of Epidemiology, 2005
- Physical Activity and Risk of Endometrial Cancer: A Report from the Shanghai Endometrial Cancer StudyCancer Epidemiology, Biomarkers & Prevention, 2005